Funding will drive commercialisation of Reactiv8 in critical US market
Mainstay Medical
Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors
Company secures FDA approval for its flagship medical device called ReActiv8
Mainstay Medical’s flagship product is now eligible for reimbursement from private health funds
Mainstay Medical cites poor liquidity in shares and cost for decision to take business private
Revenue at Irish medical device company targeting chronic back pain almost doubles
Holiday week sees thin trading in Dublin as rise in online shopping boosts Amazon
‘Day 100’ meeting reviews status of application’s review
Company submits application for pre-market approval to US regulator
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times